Have a personal or library account? Click to login
Critical Care Workers Have Lower Seroprevalence of SARS-CoV-2 IgG Compared with Non-patient Facing Staff in First Wave of COVID19 Cover

Critical Care Workers Have Lower Seroprevalence of SARS-CoV-2 IgG Compared with Non-patient Facing Staff in First Wave of COVID19

Open Access
|Aug 2021

References

  1. Zhu N, Zhang D, Wang W et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33.
  2. WHO. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update (available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports)
  3. Zheng S, Fan J, Yu F et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020;369:m1443.
  4. Shah ASV, Wood R, Gribben C et al. Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study. BMJ. 2020 Oct 28;371.
  5. Milner A, Baker E, Jeraj S et al. Race-ethnic and gender differences in representation within the English National Health Service: a quantitative analysis. BMJ Open. 2020;10(2):e034258.
  6. Williamson EJ, Walker AJ, Bhaskaran K et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-6.
  7. Abbas A, Memon SF, Khatab N et al. COVID-19 risk assessments: shortcomings in the protection of Black, Asian and Minority Ethnic healthcare workers. J Hosp Infect. 2020;106(2):385-6.
  8. WHO. Clinical management of COVID-19. Interim Guidance 2020. (available at: htps://www.who.int/publications/i/item/clinical-management-of-covid-19).
  9. Pedregosa F, Varoquaux G, Gramfort A, et al. Journal of Machine Learning Research (2011) 12. 2825-2830.
  10. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. R Core Team (2018). (Available online at htps://www.R-project.org/)
  11. Venables WN and Ripley. B.D. Modern Applied Statistics with S. Springer-Verlag. New York 2002.
  12. Fox J, Weisberg S. An R Companion to Applied Regression.3 ed. .: Sage, Thousand Oaks CA. 2019
  13. Fox J, Hong J. Effect Displays in R for Multinomial and Proportional-Odds Logit Models: Extensions to the effects Package. Journal of Statistical Software, 32(1), 1-242009.
  14. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological). 1995;57(1):289-300.
  15. Shields A, Faustini SE, Perez-Toledo M et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020. Dec;75(12):1089-1094.
  16. England PH. Weekly Coronavirus Disease 2019 (COVID-19) Surveillance Report. Summary of COVID-19 surveillance systems 2020. htps://www.gov.uk/government/news/weekly-covid-19-surveillance-report-published
  17. Struyf T, Deeks JJ, Dinnes J et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev. 2020;7:CD013665.
  18. Hashmi HAS, Asif HM. Early Detection and Assessment of Covid-19. Frontiers in Medicine. 2020;7(311).
  19. Gómez-Ochoa SA, Franco OH, Rojas LZ et al. COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes. Am J Epidemiol. 2021 Jan 4;190(1):161-175.
  20. Get a free NHS test to check if you have coronavirus. 2020. (Available online at: htps://www.gov.uk/get-coronavirus-test).
  21. Pollán M, Pérez-Gómez B, Pastor-Barriuso et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020 Aug 22;396(10250):535-544.
  22. Surkova E, Nikolayevskyy V, Drobniewski F. False-positive COVID-19 results: hidden problems and costs. Lancet Respir Med. 2020 Dec;8(12):1167-1168.
  23. Seow J, Graham C, Merrick B et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020 Dec;5(12):1598-1607.
  24. Takahashi T, Ellingson MK, Wong P et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020 Dec;588(7837):315-320.
  25. Mertz D, Kim TH, Johnstone Jet al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013 Aug 23;347.
  26. Ishiguro T, Takayanagi N, Yamaguchi S, et al. Etiology and Factors Contributing to the Severity and Mortality of Community-acquired Pneumonia. Internal Medicine. 2013;52(3):317-24.
  27. Vermillion MS, Ursin RL, Kuok DIT et al. Production of amphiregulin and recovery from influenza is greater in males than females. Biology of Sex Differences. 2018;9(1).
  28. Sekine T, Perez-Potti A, Rivera-Ballesteros O et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020 Oct 1;183(1):158-168
  29. Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13.
  30. Knight SR, Ho A, Pius R et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020 Sep 9; 370.
  31. Drefahl S, Wallace M, Mussino E et al. A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden. Nature Communications. 2020;   Oct 9;11(1):5097.
  32. SIREN (Sarscov2 Immunity & REinfection EvaluatioN): The impact of detectable anti SARS-COV2 antibody on the incidence of COVID-19 in healthcare workers. 2020. (https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/siren-sars-cov2-immunity-and-reinfection-evaluation-covid-19-uph/) )
  33. Xiong X, Qu K, Ciazynska KA, et al. A thermostable, closed SARS-CoV-2 spike protein trimer. Nat Struct Mol Biol. Oct 2020; 27(10):934-941.
  34. Stadlbauer D, Amanat F, Chromikova V, et al. SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup. Curr Protoc Microbiol. 06 2020;57(1)
  35. Pedregosa F, Varoquaux G, Gramfort A, et al. Journal of Machine Learning Research (2011) 12. 2825-2830.
DOI: https://doi.org/10.2478/jccm-2021-0018 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 199 - 210
Submitted on: Dec 21, 2020
|
Accepted on: May 28, 2021
|
Published on: Aug 5, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Helen E. Baxendale, David Wells, Jessica Gronlund, Angalee Nadesalingham, Mina Paloniemi, George Carnell, Paul Tonks, Lourdes Ceron-Gutierrez, Soraya Ebrahimi, Ashleigh Sayer, John A.G. Briggs, Xiaoli Ziong, James A Nathan, Guinevere Grice, Leo C James, Jakub Luptak, Sumita Pai, Jonathan L Heeney, Sara Lear, Rainer Doffinger, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.